## Abstract ## Background. The purpose of this study was to evaluate the efficacy and toxicity of radiotherapy and concomitant 5βfluorouracil (5βFU) and mitomycinβC infusion in inoperable head and neck cancer. ## Methods. Seventyβsix patients (86% men, 14% women), mean age 57 years, with primary
β¦ LIBER β¦
Concomitant radiochemotherapy with 5-fluorouracil and mitomycin c in locally advanced head and neck carcinoma
β Scribed by O. Pradier; E. Eberlein; E. Weiss; H. Schmidberger; C.F. Hess
- Book ID
- 117667613
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 165 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Concomitant radiochemotherapy in primary
β
Hans Christiansen; Robert M. Hermann; Andrea Hille; Elisabeth Weiss; Mirko Nitsc
π
Article
π
2004
π
John Wiley and Sons
π
English
β 534 KB
Response to preoperative concomitant rad
β
Dobrowsky, W.; Dobrowsky, E.; Strassl, H.; Braun, O.; Scheiber, V.
π
Article
π
1989
π
Elsevier Science
β 588 KB
Locally advanced pancreatic carcinoma: n
Locally advanced pancreatic carcinoma: neoadjuvant radiochemotherapy (RCT) with 5-fu and Mitomycin C
β
T.B. Brunner; G.G. Grabenbauer; S. Kastl; W. Hohenberger; R. Sauer
π
Article
π
1999
π
Elsevier Science
π
English
β 142 KB
Concomitant cisplatin and radical radiat
β
S. B. Kamboj; H. S. Hooda; V. Kaushal; B. P. Das
π
Article
π
1995
π
Springer
π
English
β 412 KB
Hyperfractionated accelerated radiochemo
β
J. Widder; W. Dobrowsky; R. Schmid; B. Pokrajac; E. Selzer; R. PΓΆtter
π
Article
π
2004
π
Elsevier Science
π
English
β 86 KB
Hyperfractionated radiation therapy and
β
AndrΓ© A. Abitbol; Kasi S. Sridhar; Alan A. Lewin; James G. Schwade; William Raub
π
Article
π
1997
π
John Wiley and Sons
π
English
β 166 KB
π 3 views
initial entry of 34 patients. Cancer Center, University of Miami School of RESULTS. At a median follow-up of 41 months (range, 12-80 months), 44 patients Medicine, Miami, Florida. were alive with a projected median overall survival of 54 months. Grade 3/4 muco-2 Regional Cancer Center, Baptist Hosp